Get started
Author

Hirohisa Kano

Observed names: H. Kano, HIROHISA KANO, Kano Hirohisa, Kano, Hirohisa
ORCID: 0000-0003-4327-7547
Observed ORCID: 0000-0003-4327-7547
OpenAlex ID: A5062219464
VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers
2021 · Hiromi Watanabe, Eiki Ichihara, et al. · Cancer Science · 56
PDF
Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)
2017 · Hiromi Watanabe, Eiki Ichihara, et al. · Internal Medicine · 43
PDF
A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)
2019 · Kiichiro Ninomiya, Tae Hata, et al. · CHEST Journal · 41
Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden
2019 · Go Makimoto, Kadoaki Ohashi, et al. · Journal of Thoracic Oncology · 34
Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer
2024 · Ayako Morita, Eiki Ichihara, et al. · International Journal of Cancer · 32
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr -Mutant Lung Cancer
2022 · Kazuya Nishii, Kadoaki Ohashi, et al. · Cancer Immunology Research · 31
Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab
2018 · Satoru Senoo, Takashi Ninomiya, et al. · Internal Medicine · 31
PDF
Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status
2020 · Hirohisa Kano, Eiki Ichihara, et al. · Cancer Science · 26
PDF
CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
2023 · Naofumi Hara, Eiki Ichihara, et al. · Translational Lung Cancer Research · 20
PDF
SHP2 Inhibition Enhances the Effects of Tyrosine Kinase Inhibitors in Preclinical Models of Treatment-naïve ALK-, ROS1- , or EGFR -altered Non–small Cell Lung Cancer
2021 · Hirohisa Kano, Eiki Ichihara, et al. · Molecular Cancer Therapeutics · 17
PDF
Randomized study comparing mannitol with furosemide for the prevention of cisplatin‐induced renal toxicity in non‐small cell lung cancer: The OLCSG1406 trial
2020 · Go Makimoto, Katsuyuki Hotta, et al. · Asia-Pacific Journal of Clinical Oncology · 16
EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice
2019 · Hisao Higo, Kadoaki Ohashi, et al. · Lung Cancer · 16
Beneficial effect of erlotinib and trastuzumab emtansine combination in lung tumors harboring EGFR mutations
2020 · Hiroe Kayatani, Kadoaki Ohashi, et al. · Biochemical and Biophysical Research Communications · 15
Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis
2020 · Satoru Senoo, Nobuaki Miyahara, et al. · PLoS ONE · 14
PDF
Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK‐rearranged non‐small cell lung cancer
2023 · Chihiro Ando, Eiki Ichihara, et al. · Cancer Science · 8
Dacomitinib as a retreatment for advanced non‐small cell lung cancer patient with an uncommon EGFR mutation
2021 · Ayako Morita, Shinobu Hosokawa, et al. · Thoracic Cancer · 8
PDF
Discomfort during bronchoscopy performed after endobronchial intubation with fentanyl and midazolam: a prospective study
2017 · Daisuke Minami, Nagio Takigawa, et al. · Japanese Journal of Clinical Oncology · 8
Comparison of bronchoscopy and computed tomography-guided needle biopsy for re-biopsy in non-small cell lung cancer patients
2021 · Hirohisa Kano, Toshio Kubo, et al. · Respiratory Investigation · 7
Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M
2018 · Satoru Senoo, Kadoaki Ohashi, et al. · Journal of Thoracic Oncology · 7
PDF
Abstract 2131: Significant combination benefit of anti-VEGFR antibody and oncogene-targeted agents in EGFR or ALK mutant NSCLC cells
2019 · Hiromi Watanabe, Eiki Ichihara, et al. · Cancer Research · 6
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study
2022 · Tomoka Nishimura, Eiki Ichihara, et al. · Cancers · 5
PDF
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction
2020 · Kazuya Nishii, Kadoaki Ohashi, et al. · Oncology Letters · 5
PDF
Granulation Tissue-induced Pseudo-relapse During Nivolumab Treatment in Advanced Non-small Cell Lung Cancer
2019 · CHIHIRO ANDO, EIKI ICHIHARA, et al. · In Vivo · 5
PDF
Impact of antibiotic use on survival in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor and chemotherapy
2025 · Nobuaki Ochi, Eiki Ichihara, et al. · International Journal of Clinical Oncology · 4
Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
2024 · Masataka Taoka, Eiki Ichihara, et al. · Cancers · 4
PDF
Works count: 49
Citation count: 468
H-index: 14
I10-index: 14
Year
Topic
Type